Loading clinical trials...
Loading clinical trials...
The aim of this study is to prospectively collect clinical information on patients with lymphoma, and to explore the best therapeutic strategies in the real-world population.
Lymphoma is a common hematological malignancy. This study aims to prospectively collect clinical information on patients with lymphoma, including the distribution of involved sites, clinical and molecular characteristics of different lymphoma subtypes, clinical treatment protocols, and prognosis, to explore the best therapeutic strategies in the real-world population.
Age
16 - No limit years
Sex
ALL
Healthy Volunteers
No
Start Date
December 18, 2025
Primary Completion Date
December 31, 2027
Completion Date
December 31, 2029
Last Updated
December 16, 2025
1,000
ESTIMATED participants
No interventions need to be specified for this study
OTHER
Lead Sponsor
Ruijin Hospital
NCT06337318
NCT05529069
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions